网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
自噬在肝癌治疗中作用的研究进展
作者:周慧琳  危安 
单位:湖南师范大学附属第一医院 超声二科, 湖南 长沙 421600
关键词:自噬 肝癌 治疗 文献综述 
分类号:R735.7
出版年·卷·期(页码):2023·51·第五期(693-698)
摘要:

肝癌是最常见的癌症之一。自噬在肝细胞癌(HCC)发生过程中具有双重作用。研究表明,自噬在肝癌治疗中的作用可能与调节微小RNAs、组蛋白去乙酰化酶(HDAC)、对化疗药的敏感性、癌症细胞干性等因素有关。阐明肝癌中自噬相关的分子机制将有助于我们开发新的HCC治疗方法。作者就目前自噬在肝癌治疗中作用的研究进展作一综述。

参考文献:

[1] CUI J,SHEN H M,LIM L.The role of autophagy in liver cancer:crosstalk in signaling pathways and potential therapeutic targets[J].Pharmaceuticals(Basel),2020,13(12):432.
[2] 孟繁坤,张嫄.原发性肝癌超声诊断新进展[J].泸州医学院学报,2016,39(5):414-417.
[3] KUDO M,FINN R S,QIN S,et al.Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma:a randomised phase 3 non-inferiority trial[J].Lancet,2018,391(10126):1163-1173.
[4] WANG Q,FENG J,TANG L.Non-coding RNA related to MAPK signaling pathway in liver cancer[J].Int J Mol Sci,2022,23(19):11908.
[5] LIU Z,LIU X,LIANG J,et al.Immunotherapy for hepatocellular carcinoma:current status and future prospects[J].Front Immunol,2021,12:765101.
[6] MARIÑO G,NISO-SANTANO M,BAEHRECKE E H,et al.Self-consumption:the interplay of autophagy and apoptosis[J].Nat Rev Mol Cell Biol,2014,15(2):81-94.
[7] SUTTON M N,HUANG G Y,LIANG X,et al.DIRAS3-derived peptide inhibits autophagy in ovarian cancer cells by binding to beclin1[J].Cancers(Basel),2019,11(4):557.
[8] SHENG X,ZHU P,QIN J,et al.The biological role of autophagy in regulating and controlling the proliferation of liver cancer cells induced by bufalin[J].Oncol Rep,2018,39(6):2931-2941.
[9] HOU X,SHAO C,SUN K,et al.Autophagy deficiency downregulates O(6)methylguanine-DNA methyltransferase and increases chemosensitivity of liver cancer cells[J].Aging(Albany NY),2021,13(10):14289-14303.
[10] YAMAMOTO H,ZHANG S,MIZUSHIMA N.Autophagy genes in biology and disease[J].Nat Rev Genet,2023,24(6):1-19.
[11] CHANG Y,LIN J,TSUNG A.Manipulation of autophagy by MIR375 generates antitumor effects in liver cancer[J].Autophagy,2012,8(12):1833-1834.
[12] LIN Z,NIU Y,WAN A,et al.RNA m(6) A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy[J].EMBO J,2020,39(12):e103181.
[13] JIAO L,ZHANG H L,LI D D,et al.Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2(hexokinase 2)[J].Autophagy,2018,14(4):671-684.
[14] LEE Y J,JANG B K.The role of autophagy in hepatocellular carcinoma[J].Int J Mol Sci,2015,16(11):26629-26643.
[15] GUNTUKU L,GANGASANI J K,THUMMURI D,et al.IITZ-01,a novel potent lysosomotropic autophagy inhibitor,has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo[J].Oncogene,2019,38(4):581-595.
[16] ZHANG H,LIANG H,WU S,et al.MicroRNA-638 induces apoptosis and autophagy in human liver cancer cells by targeting enhancer of zeste homolog 2(EZH2)[J].Environ Toxicol Pharmacol,2021,82:103559.
[17] LIAO B,SUN Q,YUAN Y,et al.Histone deacetylase inhibitor MGCD0103 causes cell cycle arrest,apoptosis,and autophagy in liver cancer cells[J].J Cancer,2020,11(7):1915-1926.
[18] DI FAZIO P,WALDEGGER P,JABARI S,et al.Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer[J].Oncotarget,2016,7(20):28998-29010.
[19] MORITA K,FURUSE M,FUJIMOTO K,et al.Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands[J].Proc Natl Acad Sci U S A,1999,96(2):511-516.
[20] MOLDVAY J,FÁBIÁN K,JÄCKEL M,et al.Claudin-1 protein expression is a good prognostic factor in non-small cell lung cancer,but only in squamous cell carcinoma cases[J].Pathol Oncol Res,2017,23(1):151-156.
[21] TONG H,LI T,QIU W,et al.Claudin-1 silencing increases sensitivity of liver cancer HepG2 cells to 5-fluorouracil by inhibiting autophagy[J].Oncol Lett,2019,18(6):5709-5716.
[22] HELMY S A,EL MESERY M,EL KAREF A,et al.Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model[J].Chem Biol Interact,2018,279:84-94.
[23] ZHANG L,FANG B.Mechanisms of resistance to TRAIL-induced apoptosis in cancer[J].Cancer Gene Ther,2005,12(3):228-237.
[24] NAZIM U M,PARK S Y.Attenuation of autophagy flux by 6-shogaol sensitizes human liver cancer cells to TRAIL-induced apoptosis via p53 and ROS[J].Int J Mol Med,2019,43(2):701-708.
[25] NAZIM U M,PARK S Y.Luteolin sensitizes human liver cancer cells to TRAIL-induced apoptosis via autophagy and JNK-mediated death receptor 5 upregulation[J].Int J Oncol,2019,54(2):665-672.
[26] HUANG X,GAN G,WANG X,et al.The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance[J].Autophagy,2019,15(7):1258-1279.
[27] HU C T,WU J R,CHENG C C,et al.The therapeutic targeting of HGF/c-Met signaling in hepatocellular carcinoma:alternative approaches[J].Cancers(Basel),2017,9(6):58.
[28] NIO K,YAMASHITA T,KANEKO S.The evolving concept of liver cancer stem cells[J].Mol Cancer,2017,16(1):4.
[29] LI J,CHEN J N,ZENG T T,et al.CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy[J].BMC Cancer,2016,16:15.
[30] SONG Y J,ZHANG S S,GUO X L,et al.Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment[J].Cancer Lett,2013,339(1):70-81.
[31] LIU K,LEE J,KIM J Y,et al.Mitophagy controls the activities of tumor suppressor p53 to regulate hepatic cancer stem cells[J].Mol Cell,2017,68(2):281-292.
[32] LAU E Y,LO J,CHENG B Y,et al.Cancer-associated fibroblasts regulate tumor-initiating cell plasticity in hepatocellular carcinoma through c-Met/FRA1/HEY1 signaling[J].Cell Rep,2016,15(6):1175-1189.
[33] CHEN W J,HO C C,CHANG Y L,et al.Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling[J].Nat Commun,2014,5:3472.
[34] ZHAO Z,BAI S,WANG R,et al.Cancer-associated fibroblasts endow stem-like qualities to liver cancer cells by modulating autophagy[J].Cancer Manag Res,2019,11:5737-5744.
[35] CHEN J,LI X,CHENG Q,et al.Effects of cyclin D1 gene silencing on cell proliferation,cell cycle,and apoptosis of hepatocellular carcinoma cells[J].J Cell Biochem,2018,119(2):2368-2380.
[36] ZHANG H.CCND1 silencing suppresses liver cancer stem cell differentiation through inhibiting autophagy[J].Hum Cell,2020,33(1):140-147.
[37] DI FAZIO P,MATROOD S.Targeting autophagy in liver cancer[J].Transl Gastroenterol Hepatol,2018,3:39.
[38] ZHAO H,JIA H,HAN Q,et al.Homeobox containing 1 inhibits liver cancer progression by promoting autophagy as well as inhibiting stemness and immune escape[J].Oncol Rep,2018,40(3):1657-1665.
[39] CHATTERJEE N,WALKER G C.Mechanisms of DNA damage,repair,and mutagenesis[J].Environ Mol Mutagen,2017,58(5):235-263.
[40] LIU E Y,XU N,O'PREY J,et al.Loss of autophagy causes a synthetic lethal deficiency in DNA repair[J].Proc Natl Acad Sci U S A,2015,112(3):773-778.
[41] ATHEW R,KARP C M,BEAUDOIN B,et al.Autophagy suppresses tumorigenesis through elimination of p62[J].Cell,2009,137(6):1062-1075.
[42] CHOI H,MERCERON C,MANGIAVINI L,et al.Hypoxia promotes noncanonical autophagy in nucleus pulposus cells independent of MTOR and HIF1A signaling[J].Autophagy,2016,12(9):1631-1646.
[43] SUN Y,ZOU H,YANG L,et al.Effect on the liver cancer cell invasion ability by studying the associations between autophagy and TRAP1 expression[J].Oncol Lett,2018,16(1):991-997.
[44] CHEN J F,WU Q S,XIE Y X,et al.TRAP1 ameliorates renal tubulointerstitial fibrosis in mice with unilateral ureteral obstruction by protecting renal tubular epithelial cell mitochondria[J].FASEB J,2017,31(10):4503-4514.
[45] QI F,ZHAO L,ZHOU A,et al.The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer[J].Biosci Trends,2015,9(1):16-34.
[46] GAO X,WANG Y,LI Y,et al.Huganpian,a traditional chinese medicine,inhibits liver cancer growth in vitro and in vivo by inducing autophagy and cell cycle arrest[J].Biomed Pharmacother,2019,120:109469.
[47] LIAO X,BU Y,JIA Q.Traditional Chinese medicine as supportive care for the management of liver cancer:Past,present,and future[J].Genes Dis,2020,7(3):370-379.
[48] XIE G,CUI Z,PENG K,et al.Aidi Injection,a traditional Chinese medicine injection,could be used as an adjuvant drug to improve quality of life of cancer patients receiving chemotherapy:a propensity score matching analysis[J].Integr Cancer Ther,2019,18:1534735418810799.
[49] CUI B,YU J M.Autophagy:a new pathway for traditional Chinese medicine[J].J Asian Nat Prod Res,2018,20(1):14-26.
[50] CHEN Z,LIU L,LIU Y,et al.Hydroxysafflor yellow A induces autophagy in human liver cancer cells by regulating Beclin 1 and ERK expression[J].Exp Ther Med,2020,19(4):2989-2996.
[51] QI W,LI Z,YANG C,et al.Inhibitory mechanism of muscone in liver cancer involves the induction of apoptosis and autophagy[J].Oncol Rep,2020,43(3):839-850.
[52] KAWANO Y,TANAKA M,FUJISHIMA M,et al.Acanthopanax senticosus Harms extract causes G0/G1 cell cycle arrest and autophagy via inhibition of Rubicon in human liver cancer cells[J].Oncol Rep,2021,45(3):1193-1201.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 752347 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541